A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2357-2364

  Lirdprapamongkol, Kriengsak ^a   Sakurai, Hiroaki ^b   Abdelhamed, Sherif ^b   Yokoyama, Satoru ^b   Maruyama, Takeyuki ^b   Athikomkulchai, Sirivan ^d   Viriyaroj, Amornrat ^d   Awale, Suresh ^b   Yagita, Hideo ^c   Ruchirawat, Somsak ^a,e,f   Svasti, Jisnuson ^a   Saiki, Ikuo ^b  

^a CHULABHORN RESEARCH INSTITUTE   (Thailand)

^b UNIVERSITY OF TOYAMA   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SRINAKHARINWIROT UNIVERSITY   (Thailand)

^e Research and Innovation   (Thailand)

^f THAILAND CENTER OF EXCELLENCE IN PHYSICS   (Thailand)

Author keywords

Antimetastatic; Hypoxia; Natural products; Propolis; STAT3

Indexed keywords

ANTIMETASTATIC AGENT; ANTINEOPLASTIC AGENT; CHRYSIN; DEATH RECEPTOR 5; FLAVONOID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DR5; NATURAL PRODUCT; PROPOLIS EXTRACT; STAT3 PROTEIN; TECTOCHRYSIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CELL CULTURE; CELL HYPOXIA; CELL STRAIN; CELL STRAIN 4T1; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MEGADOSE; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; MONOTHERAPY; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VEGF GENE;

ANIMALS; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM METASTASIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; STAT3 TRANSCRIPTION FACTOR;

EID: 84885052665     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2667     Document Type: Article

References (28)

1. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
2. Takeda K, Yamaguchi N, Akiba H, et al: Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J Exp Med 199: 437-448, 2004.
3. Hattori H, Okuda K, Murase T, et al: Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis. Bioorg Med Chem 19: 5392-5401, 2011.
4. Brizel DM, Scully SP, Harrelson JM, et al: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943, 1996.
5. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515, 1996.
6. Li XF, Carlin S, Urano M, Russell J, Ling CC and O'Donoghue JA: Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res 67: 7646-7653, 2007.
7. Li XF and O'Donoghue JA: Hypoxia in microscopic tumors. Cancer Lett 264: 172-180, 2008.
8. Iglesias P, Fraga M and Costoya JA: Defining hypoxic microenvironments by non-invasive functional optical imaging. Eur J Cancer 49: 264-271, 2013.
9. McDonnell CO, Hill AD, McNamara DA, Walsh TN and Bouchier-Hayes DJ: Tumour micrometastases: the influence of angiogenesis. Eur J Surg Oncol 26: 105-115, 2000.
10. Minet E, Michel G, Mottet D, Raes M and Michiels C: Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free Radic Biol Med 31: 847-855, 2001.
11. Jung JE, Lee HG, Cho IH, et al: STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J 19: 1296-1298, 2005.
12. Barr MP, Bouchier-Hayes DJ and Harmey JJ: Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. Int J Oncol 32: 41-48, 2008.
13. Zhang J, Lu A, Beech D, Jiang B and Lu Y: Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis. Cancer Ther 5: 273-286, 2007.
14. Sun LP, Chen AL, Hung HC, et al: Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J Agric Food Chem 60: 11748-11758, 2012.
15. Zhao X, Shu G, Chen L, Mi X, Mei Z and Deng X: A flavonoid component from Docynia delavayi (Franch.) Schneid represses transplanted H22 hepatoma growth and exhibits low toxic effect on tumor-bearing mice. Food Chem Toxicol 50: 3166-3173, 2012.
16. Fu B, Xue J, Li Z, Shi X, Jiang BH and Fang J: Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Mol Cancer Ther 6: 220-226, 2007.
17. Wagner H, Chari VM and Sonnenbichler J: 13C-NMR-spektren natürlich vorkommender flavonoide. Tetrahedron Lett 17: 1799-1802, 1976. (In German)
18. Gaydou E and Bianchini J: Etudes de composés flavoniques. I. Syntheses et propriétés (UV, RMN du 13C) de quelques flavones. Bull Soc Chim Fr II: 43-47, 1978. (In French)
19. Lirdprapamongkol K, Mahidol C, Thongnest S, et al: Anti-metastatic effects of aqueous extract of Helixanthera parasitica. J Ethnopharmacol 86: 253-256, 2003.
20. Lirdprapamongkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A and Svasti J: Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 422: 429-435, 2012.
21. Mitra SK, Mikolon D, Molina JE, et al: Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 25: 5969-5984, 2006.
22. Yang H, Xu Z, Iuvone PM and Grossniklaus HE: Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model. Mol Vis 12: 511-517, 2006.
23. Lin CM, Shyu KG, Wang BW, Chang H, Chen YH and Chiu JH: Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach. J Agric Food Chem 58: 7082-7087, 2010.
24. Walle T, Otake Y, Brubaker JA, Walle UK and Halushka PV: Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol 51: 143-146, 2001.
25. Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB and Chambers AF: Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 65: 3396-3403, 2005.
26. Huang J, Frischer JS, Serur A, et al: Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci USA 100: 7785-7790, 2003.
27. Guba M, von Breitenbuch P, Steinbauer M, et al: Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8: 128-135, 2002.
28. Lunt SJ, Cawthorne C, Ali M, et al: The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy. Br J Cancer 103: 201-208, 2010.